1. Home
  2. SPRO vs TAYD Comparison

SPRO vs TAYD Comparison

Compare SPRO & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

N/A

Current Price

$63.24

Market Cap

132.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
TAYD
Founded
2013
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.7M
132.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
TAYD
Price
$2.28
$63.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
281.7K
7.8K
Earning Date
11-13-2025
01-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.72
Revenue
$40,549,000.00
$44,593,219.00
Revenue This Year
N/A
$10.81
Revenue Next Year
N/A
$8.37
P/E Ratio
N/A
$22.67
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$29.50
52 Week High
$3.22
$62.00

Technical Indicators

Market Signals
Indicator
SPRO
TAYD
Relative Strength Index (RSI) 45.17 78.49
Support Level $2.26 $58.58
Resistance Level $2.37 $62.00
Average True Range (ATR) 0.07 2.43
MACD -0.00 0.55
Stochastic Oscillator 12.12 100.00

Price Performance

Historical Comparison
SPRO
TAYD

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: